Ollin Biosciences | RoundOS

Weekly digest by email

Loading companies…

Ollin Biosciences | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jun 24, 2026	Series B	$330M	a16z Bio+Health — Role not disclosedARCH Venture Partners — Role not disclosedBlackstone Multi-Asset Investing — Role not disclosedCanada Pension Plan Investment Board — Role not disclosedCommodore Capital — Role not disclosedMonograph Capital — Role not disclosedMubadala Capital — Role not disclosedRA Capital Management — Role not disclosedTCGX — Role not disclosedT. Rowe Price Investment Management — Role not disclosed

Investors

a16z Bio+HealthSeries B ARCH Venture PartnersSeries B Blackstone Multi-Asset InvestingSeries B Canada Pension Plan Investment BoardSeries B Commodore CapitalSeries B Monograph CapitalSeries B Mubadala CapitalSeries B RA Capital ManagementSeries B TCGXSeries B T. Rowe Price Investment ManagementSeries B

Coverage

Jun 24, 2026Ollin Biosciences · Series B

Similar companies

OwnerProvides an AI-powered technology and marketing platform for local businesses$240M · Series D

Warpify RoboticsBuilds robot productivity infrastructure for deployment, leasing and RaaS modelsUndisclosed · Seed+

AdvisarAI decisioning layer helping retail suppliers measure retail media investment ROI$750K · Pre-Seed

Sources